Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

BMC cancer·2022
Same author

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.

ESMO open·2022
Same author

Focusing on Diabetic Ulcers.

Translational medicine @ UniSa·2020
Same author

Acute Deep Vein Thrombosis and Pulmonary Embolism: is the Thromboaspiration Device an Appropriate Choice?

Translational medicine @ UniSa·2020
Same author

Well-differentiated papillary mesothelioma of the tunica vaginalis: Case report and literature review.

Urology case reports·2018
Same author

Peritoneal tuberculosis associated with adrenocorticol primitive neoplasm mimicking a peritoneal carcinosis: a case report.

European journal of gynaecological oncology·2018
Same journal

The current standing of standard PCNL in the era of miniaturization.

Urologia·2026
Same journal

Thanks to Reviewers.

Urologia·2026
Same journal

Cutaneous ureterostomy versus ileal conduit as urinary diversion in patients with muscle-invasive bladder cancer undergoing radical cystectomy: A comparative analysis of high-risk cases.

Urologia·2026
Same journal

Do we have to do ureteric reimplantation during augmentation cystoplasty in patients with spastic neurogenic bladder?

Urologia·2026
Same journal

Multiomics empowers predictive drug resistance in advanced prostate cancer.

Urologia·2026
Same journal

Spectrum of genital findings in ART-conceived male neonates: A blinded case series analyzing parental reproductive history.

Urologia·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Erectile dysfunction and alcohol intake.

G Dachille, M Lamuraglia, M Leone

    Urologia
    |November 19, 2010
    PubMed
    Summary
    This summary is machine-generated.

    This study found that high alcohol consumption significantly correlates with erectile dysfunction (ED). Alcohol abstinence is crucial for improving ED treatment outcomes, especially in patients with high alcohol risk.

    More Related Videos

    Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
    08:13

    Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

    Published on: May 18, 2020

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
    05:12

    Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

    Published on: June 23, 2023

    Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
    08:13

    Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

    Published on: May 18, 2020

    Area of Science:

    • Urology
    • Andrology
    • Addiction Medicine

    Background:

    • Erectile dysfunction (ED) is a common condition affecting men's health.
    • Alcohol consumption is a potential contributing factor to ED.
    • Understanding the relationship between alcohol use and ED is vital for effective treatment.

    Purpose of the Study:

    • To investigate the influence of alcohol consumption on erectile dysfunction.
    • To assess the impact of alcohol abstinence on ED treatment response.
    • To evaluate the combined effect of sildenafil and alcohol abstinence.

    Main Methods:

    • 50 male patients with erectile dysfunction were assessed using questionnaires for alcohol risk and the International Index Erectile Dysfunction (IIEF).
    • Patients were divided into treatment groups and evaluated before and after one month of intervention.
    • Penile Doppler Ultrasound was used to assess vascular parameters like peak systolic velocity (PSV) and diastolic peak velocity (PDV).

    Main Results:

    • A significant relationship was found between alcohol consumption levels and ED severity, with high-risk drinkers showing poorer outcomes.
    • 29 out of 50 patients responded to therapy, while 21 did not.
    • Abnormal penile Doppler Ultrasound findings, particularly low PDV, were strongly correlated with high alcohol consumption risk (p=0.00001).

    Conclusions:

    • Alcohol consumption is a significant factor in the development and severity of erectile dysfunction.
    • Alcohol abstinence demonstrates therapeutic value in managing ED.
    • Identifying and addressing alcohol consumption risk is essential for successful ED treatment strategies.